Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 28, 2008; 14(8): 1274-1279
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1274
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1274
Figure 3 Proliferation selectivity of CNHK300-GFP in Hep3B (upper) and BJ (lower) under fluorescence microscope.
CNHK300-GFP could infect both BJ cells and Hep3B cells. But after days of infection, CNHK300-GFP virus could proliferate effectively in cancer cells and induced cytopathologic effect (CPE) at d 7, whereas in normal cell lines, CNHK300-GFP proliferation was attenuated, and BJ cells did not show CPE after days of infection.
- Citation: Li YM, Song ST, Jiang ZF, Zhang Q, Su CQ, Liao GQ, Qu YM, Xie GQ, Li MY, Ge FJ, Qian QJ. Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma. World J Gastroenterol 2008; 14(8): 1274-1279
- URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1274.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1274